AT-tributable risks?

BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer (1999) 1.71

Molecular pathology of ataxia telangiectasia. J Clin Pathol (2005) 1.59

Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet (1999) 1.51

Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res (2011) 1.36

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer (1999) 1.30

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer (1999) 1.29

ATM protein synthesis patterns in sporadic breast cancer. Mol Pathol (1999) 0.95

Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer (1997) 0.93

Role of the ataxia-telangiectasia gene (ATM) in breast cancer. A-T heterozygotes seem to have an increased risk but its size is unknown. BMJ (1998) 0.91

ATM variants and cancer risk in breast cancer patients from Southern Finland. BMC Cancer (2006) 0.90

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. Fam Cancer (2012) 0.88

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer. Iran J Public Health (2011) 0.85

More breast cancer genes? Breast Cancer Res (2001) 0.79

Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet (1997) 3.66

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09

Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994) 9.60

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 9.06

Construction of linkage maps with DNA markers for human chromosomes. Nature (1985) 6.38

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06

Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11

EXPERIMENTAL HYPERTONICITY: ALTERATIONS IN THE DISTRIBUTION OF BODY WATER, AND THE CAUSE OF DEATH. J Clin Invest (1944) 3.96

Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01

The association of cancer and the nephrotic syndrome. Ann Intern Med (1966) 2.88

A model for restriction fragment length distributions. Am J Hum Genet (1983) 2.71

The information content of phase-known matings for ordering genetic loci. Genet Epidemiol (1985) 2.59

Case-control study of whether subfertility in men is familial. BMJ (1994) 2.49

Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26

Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol (1996) 2.00

The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet (1986) 1.90

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70

Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64

Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol (1982) 1.61

Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med (1985) 1.58

Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis (2003) 1.54

Intron splice acceptor site sequence variation in the hereditary non-polyposis colorectal cancer gene hMSH2. Eur J Cancer (1994) 1.54

Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia (1995) 1.54

Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol (1994) 1.53

Adherence to asthma management guidelines by middle-aged adults with current asthma. Thorax (2009) 1.50

Frequency of replication errors in colorectal cancer and their association with family history. Gut (1998) 1.46

Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol (1993) 1.45

Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol (2009) 1.45

Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1990) 1.44

Interstitial nephritis in Sjögren's syndrome. Ann Intern Med (1968) 1.44

Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas. Mol Pathol (2003) 1.42

Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer? Gut (1998) 1.42

Elective use of cannula cricothyroidotomy. Anaesthesia (2011) 1.39

Frequency of familial colorectal cancer. Br J Surg (1991) 1.38

A comparative study of radionuclide venography and contrast venography in the diagnosis of deep venous thrombosis. Aust N Z J Med (1993) 1.38

A case-control study of diet and prostate cancer. Br J Cancer (1997) 1.32

Menopausal symptoms in Australian women. Med J Aust (1993) 1.32

A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer (1997) 1.31

Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry (1992) 1.29

Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet (1993) 1.27

The treatment-seeking woman at menopause. Maturitas (1994) 1.25

The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol (2004) 1.25

Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet (2005) 1.25

The impact of RFLPs on human gene mapping. Prog Clin Biol Res (1984) 1.24

Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features. Kidney Int (1987) 1.22

A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet (1999) 1.21

Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet (1997) 1.19

Possible linkage of a breast cancer-susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation. Genet Epidemiol (1984) 1.13

Distribution of lod scores under uncertain mode of inheritance. Am J Hum Genet (1993) 1.12

The regulatory protein GAL80 is a determinant of the chromatin structure of the yeast GAL1-10 control region. J Biol Chem (1987) 1.11

Factors in the cycle of violence: gender rigidity and emotional constriction. J Trauma Stress (1996) 1.11

Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet (1996) 1.09

Changes in axial bone density with age: a twin study. J Bone Miner Res (1993) 1.09

Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Medicine (Baltimore) (1978) 1.08

Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut (1993) 1.07

Germline BRCA2 mutations in men with breast cancer. Br J Cancer (1997) 1.07

Quantitating genetic and nongenetic factors that determine plasma sex steroid variation in normal male twins. Metabolism (1986) 1.06

The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet (1999) 1.06

Autozygosity mapping, complex consanguinity, and autosomal recessive disorders. J Med Genet (1993) 1.05

Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens Suppl (1986) 1.05

The TERT variant rs2736100 is associated with colorectal cancer risk. Br J Cancer (2012) 1.05

Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.05

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer (2005) 1.04

Awareness under anesthesia and the development of posttraumatic stress disorder. Gen Hosp Psychiatry (2001) 1.04

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04

Diagnostic import of virus-like particles in the glomerular endothelium of patients with systemic lupus erythematosus. N Engl J Med (1970) 1.03

Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer (1997) 1.03

Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ (1995) 1.03

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol (2000) 1.03

Linkage analysis of early-onset breast and ovarian cancer families, with markers on the long arm of chromosome 17. Am J Hum Genet (1993) 1.02

Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity. Mol Diagn (1999) 1.02

A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet (2001) 1.01

Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br J Cancer (1999) 1.01

Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis. Hum Pathol (1985) 1.01

A generalized war of attrition. J Theor Biol (1978) 1.01

Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br J Surg (1994) 1.01

Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer (2000) 1.01

Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits. Seizure (1997) 1.00

Lipoid nephrosis in 31 adult patients: renal biopsy study by light, electron, and fluorescence microscopy with experience in treatment. Medicine (Baltimore) (1970) 1.00

Heritability of variation of plasma cortisol levels. Metabolism (1988) 1.00

The information content from renal biopsy in systemic lupus erythematosus. Ann Intern Med (1982) 0.99

Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer (2010) 0.99

Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol (1998) 0.99

Socioeconomic status and cancer mortality and incidence in Melbourne. Eur J Cancer (1991) 0.99

Characteristics of familial colon cancer in a large population data base. Cancer (1989) 0.98

Suggested screening guidelines for familial colorectal cancer. J Med Screen (1995) 0.98

Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J Pathol (2001) 0.98

A retrospective observational study of the relationship between family history and survival from colorectal cancer. Br J Cancer (2013) 0.97

Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet (1994) 0.97

Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst (2001) 0.97

Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis. Hum Genet (1997) 0.96

Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J Clin Endocrinol Metab (1988) 0.96

Incidence of DNA replication errors in patients with multiple primary cancers. Dis Colon Rectum (1998) 0.96

Candidate regions for a testicular cancer susceptibility gene. Hum Mol Genet (1995) 0.95

Genetic predisposition to cancer. Important Adv Oncol (1991) 0.94

Membranous nephropathy: predictors of terminal renal failure. Nephron (1984) 0.94

Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine (Baltimore) (1983) 0.93

Familial risk and genetic susceptibility for breast cancer. Cancer Causes Control (1994) 0.93

Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation. Diabetes Care (1993) 0.93

Renal vein thrombosis in membranous glomerulonephropathy: incidence and association. Medicine (Baltimore) (1978) 0.92